HomeCONGRESS

CONGRESS

View Category
Day 1

TCT Session

Alan Wilson and Szeto Zajarias show that vascular complications of the trans-femoral path remain an important factor...
solaci -
Learn More
Day 1

PREVAIL: LAA occlusion versus anticoagulation with warfarin to prevent stroke in patients with non-valvular atrial fibrillation.

An hour before the presentation of the PREVAIL study, the ACC announced the cancellation of the release...
solaci -
Learn More
Day 1

THRIVE: Niacin/laropiprant extended release showed no significant cardiovascular benefit.

The THRIVE study, (also known as HPS2-THRIVE), was a multicenter clinical trial designed to test the hypothesis...
solaci -
Learn More
SOLACI Session

How to prevent TAVI complications with current technology

Antonio Dager2013-05-21
solaci -
Learn More
SOLACI Session

TAVI: case complication

Marco Perin2013-05-21
solaci -
Learn More
SOLACI Session

Why we should close patent foramen ovale (PFO)

Ralph Stephan von Bardeleben2013-05-21
solaci -
Learn More
SOLACI Session

Value of New Devices for Improving Outcomes

Eberhard Grube2013-05-21
solaci -
Learn More
SOLACI Session

Mitral valve repair: were we are and what we would expect for LATAM in the near future

Magnus Seergren2013-08-21
solaci -
Learn More